한글목차

세계의 의약품 수탁판매 시장 규모는 2033년까지 8.2%의 CAGR로 성장할 것으로 예측되고 있습니다.

업계의 주요 기업은 CRO(임상시험수탁기관)와 CSO(임상시험수탁기관)의 업무를 통합하여 큰 이익을 창출하고 있습니다. 일부 유명 CRO 업체들은 M&A를 통해 자사의 서비스와 상업화 능력을 효과적으로 통합하여 의약품 개발 과정 전반에 걸쳐 고객에게 종합적인 솔루션을 제공할 수 있도록 하고 있습니다.

이러한 전략적 움직임의 대표적인 예로는 INC Research의 인수와 이후 Syneos로의 브랜드 변경, Quintiles의 IMS 인수 등을 들 수 있습니다. 마찬가지로 2023년 1월 Publicis Groupe는 불가리아의 유명 퍼포먼스 마케팅 에이전시인 Advertise BG를 인수한다고 밝혔습니다. 이 전략적 움직임은 디지털 전략, 데이터 분석, 소셜미디어 관리 및 디지털 컨텐츠 제작 서비스를 강화하고 디지털 혁신에 대한 Publicis Groupe Bulgaria의 역량을 강화하는 것을 목표로 하고 있습니다.

최근 수년간 제약 산업은 다양화 및 전문화를 통해 큰 변화를 겪고 있으며, 이러한 변화로 인해 세계 의약품 위탁 판매 서비스에 대한 수요도 증가하고 있습니다. 제약사들이 제품 포트폴리오를 확장하고 더 넓은 치료 영역을 커버함에 따라 다양한 제품을 효과적으로 홍보하고 판매해야 하는 과제에 직면해 있습니다.

제약 위탁판매 서비스는 전문 영업팀과 맞춤형 마케팅 전략을 통해 전략적 솔루션을 제공합니다. 이러한 서비스를 통해 제약회사는 풍부한 업계 지식과 네트워크를 갖춘 숙련된 전문가에게 접근하여 다양한 제품군의 효율적인 시장 침투를 가능하게 합니다. 또한 위탁 판매 서비스가 제공하는 비용 효율성과 유연성은 자원 배분을 최적화하고자 하는 기업에게 매력적인 선택이 될 수 있습니다.

세계의 의약품 수탁판매 시장을 조사했으며, 시장 개요, 시장 성장에 대한 각종 영향요인 분석, 시장 규모의 추이·예측, 각종 구분·지역/주요 국가별 내역, 경쟁 환경, 주요 기업의 개요 등을 정리하여 전해드립니다.

목차

제1장 리포트 개요

제2장 주요 요약

제3장 시장 개요

• 주요 조사 결과
• 시장 역학
  • 시장 촉진요인
  • 시장 억제요인
  • 시장 기회
• COVID-19의 영향 분석
• Porter's Five Forces 분석
• PEST 분석

제4장 의약품 수탁판매 시장 분석 : 유형별

• 주요 조사 결과
• 시장 매력 지수
• 시장 규모 추산·예측
• 퍼스널 프로모션
  • 프로모션 세일즈 팀
  • 공석 관리
  • 헬스케어 전문가
• 비퍼스널 프로모션
  • 컨택센터
  • 원격 디테일링
  • 의료 콜센터
  • 원격 샘플링
  • 온라인 서비스
• 공동 프로모션
  • 시장조사 & 컨설팅
  • 제품 상품화
  • Territory 최적화·조정
  • 브랜드 매니지먼트
  • 성숙 제품 라인 지원
  • 기타

제5장 의약품 수탁판매 시장 분석 : 치료 영역별

• 주요 조사 결과
• 시장 매력 지수
• 시장 규모 추산·예측
• 종양
• 면역
• 당뇨병
• 순환기 질환
• 호흡기
• 중추신경계
• 기타

제6장 의약품 수탁판매 시장 분석 : 지역별

• 주요 조사 결과
• 시장 규모 추산·예측

제7장 북미의 의약품 수탁판매 시장 분석

제8장 유럽의 의약품 수탁판매 시장 분석

제9장 아시아태평양의 의약품 수탁판매 시장 분석

제10장 라틴아메리카의 의약품 수탁판매 시장 분석

제11장 중동 및 아프리카의 의약품 수탁판매 시장 분석

제12장 기업 개요

• 경쟁 구도
• 전략적 전망
• CMIC HOLDINGS Co., LTD.
• IQVIA Inc.
• Syneos Health
• Inizio Group Limited
• Uniphar Group Plc
• ICON plc
• Amplity Health
• Apodi
• Marvecs GmbH
• ONCALL, LLC.
• PUBLICIS GROUPE
• SOFIP
• Granard Pharmaceutical Sales &Marketing
• Vanguard Pharma
• GTS Solution
• MaBiCo
• Sales Partnerships, Inc.
• QFR Solution

제13장 결론·제안

• Visiongain으로부터의 결론
• 시장 참여 기업에 대한 제안

영문목차

The global Pharma Contract Sales market is projected to grow at a CAGR of 8.2% by 2033.

“The Pharma Contract Sales Market Report 2023-2033”: This report will prove invaluable to leading firms striving for new revenue pockets if they wish to better understand the industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region.

Global Players Consolidating CRO and CSO Operations to Offer End-to-end Services

Major industry players are integrating Contract Research Organization (CRO) and Contract Sales Organization (CSO) operations, resulting in significant benefits. Several prominent CRO providers have effectively combined their services with commercialization capabilities through mergers and acquisitions (M&A), enabling them to offer comprehensive solutions to clients across the drug development journey.

Notable instances of such strategic moves include INC Research's acquisition and subsequent rebranding as Syneos, as well as Quintiles' acquisition of IMS. Similarly, in January 2023, Publicis Groupe recently revealed their acquisition of Advertise BG, a prominent performance marketing agency in Bulgaria. This strategic move aims to enhance Publicis Groupe Bulgaria's capabilities in digital transformation, bolstering their services in digital strategy, data analytics, social media management, and digital content production.

This trend towards consolidation and integration within the CRO and CSO landscape is expected to fuel the demand for contract sales services. The seamless integration of research, development, and commercialization services facilitates a more streamlined and efficient drug development process. Clients seeking a holistic and efficient approach are likely to increasingly turn to providers offering end-to-end solutions, further stimulating the demand for contract sales services.

Growing Demand for Pharma Contract Sales Services

In recent years, the pharmaceutical industry has witnessed a significant transformation marked by diversification and specialization. This evolution has led to an increased demand for pharma contract sales services worldwide. As pharmaceutical companies expand their product portfolios to encompass a broader range of therapeutic areas, they face the challenge of effectively promoting and distributing these diverse offerings.

Pharma contract sales services provide a strategic solution by offering specialized sales teams and tailored marketing strategies. These services allow pharmaceutical companies to access experienced professionals with deep industry knowledge and networks, enabling efficient market penetration for their varied product lines. Additionally, the cost-effectiveness and flexibility offered by contract sales services make them an attractive option for companies looking to optimize resource allocation.

Furthermore, globalization has expanded market reach, requiring companies to adapt to various regulatory environments and market dynamics. Pharma contract sales services facilitate this adaptation by providing local expertise and understanding of regional markets, ensuring compliance and effective engagement with healthcare professionals.

In conclusion, the diversification of the pharmaceutical industry has heightened the need for agile and specialized sales and marketing approaches. Pharma contract sales services have emerged as a crucial tool in meeting these evolving demands, ultimately enhancing the industry's ability to effectively reach and serve diverse markets.

What Questions Should You Ask before Buying a Market Research Report?

• How is the Pharma Contract Sales market evolving?
• What is driving and restraining the Pharma Contract Sales market?
• How will each Pharma Contract Sales submarket segment grow over the forecast period and how much revenue will these submarkets account for in 2033?
• How will the market shares for each Pharma Contract Sales submarket develop from 2023 to 2033?
• What will be the main driver for the overall market from 2023 to 2033?
• Will leading Pharma Contract Sales markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others?
• How will the market shares of the national markets change by 2033 and which geographical region will lead the market in 2033?
• Who are the leading players and what are their prospects over the forecast period?
• What are the Pharma Contract Sales projects for these leading companies?
• How will the industry evolve during the period between 2023 and 2033? What are the implications of Pharma Contract Sales projects taking place now and over the next 10 years?
• Is there a greater need for product commercialisation to further scale the Pharma Contract Sales market?
• Where is the Pharma Contract Sales market heading and how can you ensure you are at the forefront of the market?
• What are the best investment options for new product and service lines?
• What are the key prospects for moving companies into a new growth path and C-suite?

You need to discover how this will impact the Pharma Contract Sales market today, and over the next 10 years:

• Our 304-page report provides 128 tables and 172 charts/graphs exclusively to you
• The report highlights key lucrative areas in the industry so you can target them - NOW
• It contains in-depth analysis of global, regional and national sales and growth
• It highlights for you the key successful trends, changes and revenue projections made by your competitors.

This report tells you TODAY how the Pharma Contract Sales market will develop in the next 10 years, and in line with the variations in COVID-19 economic recession and bounce. This market is more critical now than at any point over the last 10 years.

• In addition to revenue forecasting to 2033, our new study provides you with recent results, growth rates, and market shares
• You will find original analyses, with business outlooks and developments
• Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), cost structure, impact of rising Pharma Contract Sales prices and recent developments.

This report includes data analysis and invaluable insight into how COVID-19 will affect the industry and your company. Four COVID-19 recovery patterns and their impact, namely, ""V" ", "L", "W" and "U" are discussed in this report.

Segments Covered in the Report:

Type

• Personal Promotion
  • Promotional Sales Team
  • Vacancy Management
  • Health Care Professional

• Non-personal Promotion
  • Contact Centre
  • Tele-detailing
  • Medical Call Centres
  • Telesampling
  • Online Services

• Co-promotion
  • Marketing Research and Consulting
  • Product Commercialization
  • Territory Optimization and Alignment
  • Brand Management
  • Mature Product Line Support
  • Rest All CSO Services

Therapeutics

• Oncology
• Immunology
• Diabetes
• Cardiovascular Disease
• Respiratory
• CNS
• Others

In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for five regional and 21 leading national markets:

North America

• U.S
• Canada

Europe

• Germany
• UK
• France
• Spain
• Italy
• Russia
• Rest of Europe

Asia Pacific

• China
• Japan
• India
• Australia
• South Korea
• Rest of Asia Pacific

Latin America

• Brazil
• Mexico
• Rest of Latin America

MEA

• GCC
• South Africa
• Rest of MEA

The report also includes profiles and for some of the leading companies in the Pharma Contract Sales Market, 2023 to 2033, with a focus on this segment of these companies' operations.

Leading companies profiled in the report:

Overall world revenue for Pharma Contract Sales Market, 2023 to 2033 in terms of value the market will surpass US$7,600 million in 2023, our work calculates. We predict strong revenue growth through to 2033. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.

How will the Pharma Contract Sales Market, 2023 to 2033 report help you?

In summary, our 300+ page report provides you with the following knowledge:

• Revenue forecasts to 2033 for Pharma Contract Sales Market, 2023 to 2033 Market, with forecasts for type and therapeutics each forecast at a global and regional level - discover the industry's prospects, finding the most lucrative places for investments and revenues.
• Revenue forecasts to 2033 for five regional and 21 key national markets - See forecasts for the Pharma Contract Sales Market, 2023 to 2033 market in North America, Europe, Asia-Pacific, Latin America, and MEA. Also forecasted is the market in the US, Canada, Mexico, Brazil, Germany, France, UK, Italy, China, India, Japan, and Australia among other prominent economies.
• Prospects for established firms and those seeking to enter the market - including company profiles for 18 of the major companies involved in the Pharma Contract Sales Market, 2023 to 2033.

Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with invaluable business intelligence.

Information found nowhere else

With our new report, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. Our study is for everybody needing commercial analyses for the Pharma Contract Sales Market, 2023 to 2033, market-leading companies. You will find data, trends and predictions.

Table of Contents

1 Report Overview

• 1.1 Objectives of the Study
• 1.2 Introduction to Pharma Contract Sales Market
• 1.3 What This Report Delivers
• 1.4 Why You Should Read This Report
• 1.5 Key Questions Answered by This Analytical Report
• 1.6 Who is This Report for?
• 1.7 Methodology
  • 1.7.1 Market Definitions
  • 1.7.2 Market Evaluation & Forecasting Methodology
  • 1.7.3 Data Validation
    • 1.7.3.1 Primary Research
    • 1.7.3.2 Secondary Research
• 1.8 Frequently Asked Questions (FAQs)
• 1.9 Associated Visiongain Reports
• 1.10 About Visiongain

2 Executive Summary

3 Market Overview

• 3.1 Key Findings
• 3.2 Market Dynamics
  • 3.2.1 Market Driving Factors
    • 3.2.1.1 Growing Significance of Data in Pharma to Drive the Market Demand
    • 3.2.1.2 Global Players Consolidating CRO and CSO Operations to Offer End-to-end Services
    • 3.2.1.3 Transforming Pharma Sales: Technology and Outsourcing in the Pharmaceutical Services Industry
  • 3.2.2 Market Restraining Factors
    • 3.2.2.1 Quality Challenges in the Competitive Contract Pharma Services Market
    • 3.2.2.2 Navigating Regulatory Hurdles and Timelines in Pharmaceutical Contract Manufacturing
  • 3.2.3 Market Opportunities
    • 3.2.3.1 Rising Opportunities for Pharmaceutical Expansion in Asian Markets
    • 3.2.3.2 Diversification Trends in the Pharma Industry: Increasing Inorganic and Organic Activities to Create Market Opportunities
• 3.3 COVID-19 Impact Analysis
• 3.4 Porter's Five Forces Analysis
  • 3.4.1 Bargaining Power of Suppliers
  • 3.4.2 Bargaining Power of Buyers
  • 3.4.3 Competitive Rivalry
  • 3.4.4 Threat from Substitutes
  • 3.4.5 Threat of New Entrants
• 3.5 PEST Analysis

4 Pharma Contract Sales Market Analysis by Type

• 4.1 Key Findings
• 4.2 Type Segment: Market Attractiveness Index
• 4.3 Pharma Contract Sales Market Size Estimation and Forecast by Type
• 4.4 Personal Promotion
  • 4.4.1 Market Size by Region, 2023-2033 (US$ Million)
  • 4.4.2 Market Share by Region, 2023 & 2033 (%)
  • 4.4.3 Promotional Sales Team
    • 4.4.3.1 Market Size by Region, 2023-2033 (US$ Million)
    • 4.4.3.2 Market Share by Region, 2023 & 2033 (%)
  • 4.4.4 Vacancy Management
    • 4.4.4.1 Market Size by Region, 2023-2033 (US$ Million)
    • 4.4.4.2 Market Share by Region, 2023 & 2033 (%)
  • 4.4.5 Health Care Professional
    • 4.4.5.1 Market Size by Region, 2023-2033 (US$ Million)
    • 4.4.5.2 Market Share by Region, 2023 & 2033 (%)
• 4.5 Non-personal Promotion
  • 4.5.1 Market Size by Region, 2023-2033 (US$ Million)
  • 4.5.2 Market Share by Region, 2023 & 2033 (%)
  • 4.5.3 Contact Centre
    • 4.5.3.1 Market Size by Region, 2023-2033 (US$ Million)
    • 4.5.3.2 Market Share by Region, 2023 & 2033 (%)
  • 4.5.4 Tele-detailing
    • 4.5.4.1 Market Size by Region, 2023-2033 (US$ Million)
    • 4.5.4.2 Market Share by Region, 2023 & 2033 (%)
  • 4.5.5 Medical Call Centres
    • 4.5.5.1 Market Size by Region, 2023-2033 (US$ Million)
    • 4.5.5.2 Market Share by Region, 2023 & 2033 (%)
  • 4.5.6 Telesampling
    • 4.5.6.1 Market Size by Region, 2023-2033 (US$ Million)
    • 4.5.6.2 Market Share by Region, 2023 & 2033 (%)
  • 4.5.7 Online Services
    • 4.5.7.1 Market Size by Region, 2023-2033 (US$ Million)
    • 4.5.7.2 Market Share by Region, 2023 & 2033 (%)
• 4.6 Co-promotion
  • 4.6.1 Market Size by Region, 2023-2033 (US$ Million)
  • 4.6.2 Market Share by Region, 2023 & 2033 (%)
  • 4.6.3 Marketing Research and Consulting
    • 4.6.3.1 Market Size by Region, 2023-2033 (US$ Million)
    • 4.6.3.2 Market Share by Region, 2023 & 2033 (%)
  • 4.6.4 Product Commercialization
    • 4.6.4.1 Market Size by Region, 2023-2033 (US$ Million)
    • 4.6.4.2 Market Share by Region, 2023 & 2033 (%)
  • 4.6.5 Territory Optimization & Alignment
    • 4.6.5.1 Market Size by Region, 2023-2033 (US$ Million)
    • 4.6.5.2 Market Share by Region, 2023 & 2033 (%)
  • 4.6.6 Brand Management
    • 4.6.6.1 Market Size by Region, 2023-2033 (US$ Million)
    • 4.6.6.2 Market Share by Region, 2023 & 2033 (%)
  • 4.6.7 Mature Product Line Support
    • 4.6.7.1 Market Size by Region, 2023-2033 (US$ Million)
    • 4.6.7.2 Market Share by Region, 2023 & 2033 (%)
  • 4.6.8 Rest All CSO Services
    • 4.6.8.1 Market Size by Region, 2023-2033 (US$ Million)
    • 4.6.8.2 Market Share by Region, 2023 & 2033 (%)

5 Pharma Contract Sales Market Analysis by Therapeutics

• 5.1 Key Findings
• 5.2 Therapeutics Segment: Market Attractiveness Index
• 5.3 Pharma Contract Sales Market Size Estimation and Forecast by Therapeutics
• 5.4 Oncology
  • 5.4.1 Market Size by Region, 2023-2033 (US$ Million)
  • 5.4.2 Market Share by Region, 2023 & 2033 (%)
• 5.5 Immunology
  • 5.5.1 Market Size by Region, 2023-2033 (US$ Million)
  • 5.5.2 Market Share by Region, 2023 & 2033 (%)
• 5.6 Diabetes
  • 5.6.1 Market Size by Region, 2023-2033 (US$ Million)
  • 5.6.2 Market Share by Region, 2023 & 2033 (%)
• 5.7 Cardiovascular Disease
  • 5.7.1 Market Size by Region, 2023-2033 (US$ Million)
  • 5.7.2 Market Share by Region, 2023 & 2033 (%)
• 5.8 Respiratory
  • 5.8.1 Market Size by Region, 2023-2033 (US$ Million)
  • 5.8.2 Market Share by Region, 2023 & 2033 (%)
• 5.9 CNS
  • 5.9.1 Market Size by Region, 2023-2033 (US$ Million)
  • 5.9.2 Market Share by Region, 2023 & 2033 (%)
• 5.10 Others
  • 5.10.1 Market Size by Region, 2023-2033 (US$ Million)
  • 5.10.2 Market Share by Region, 2023 & 2033 (%)

6 Pharma Contract Sales Market Analysis by Region

• 6.1 Key Findings
• 6.2 Regional Market Size Estimation and Forecast

7 North America Pharma Contract Sales Market Analysis

• 7.1 Key Findings
• 7.2 North America Pharma Contract Sales Market Attractiveness Index
• 7.3 North America Pharma Contract Sales Market by Country, 2023, 2028 & 2033 (US$ Million)
• 7.4 North America Pharma Contract Sales Market Size Estimation and Forecast by Country
• 7.5 North America Pharma Contract Sales Market Size Estimation and Forecast by Type
  • 7.5.1 North America Pharma Contract Sales Market Size Estimation and Forecast by Personal Promotion
  • 7.5.2 North America Pharma Contract Sales Market Size Estimation and Forecast by Non-personal Promotion
  • 7.5.3 North America Pharma Contract Sales Market Size Estimation and Forecast by Co-promotion
• 7.6 North America Pharma Contract Sales Market Size Estimation and Forecast by Therapeutics
• 7.7 U.S. Pharma Contract Sales Market Analysis
• 7.8 Canada Pharma Contract Sales Market Analysis

8 Europe Pharma Contract Sales Market Analysis

• 8.1 Key Findings
• 8.2 Europe Pharma Contract Sales Market Attractiveness Index
• 8.3 Europe Pharma Contract Sales Market by Country, 2023, 2028 & 2033 (US$ Million)
• 8.4 Europe Pharma Contract Sales Market Size Estimation and Forecast by Country
• 8.5 Europe Pharma Contract Sales Market Size Estimation and Forecast by Type
  • 8.5.1 Europe Pharma Contract Sales Market Size Estimation and Forecast by Personal Promotion
  • 8.5.2 Europe Pharma Contract Sales Market Size Estimation and Forecast by Non-personal Promotion
  • 8.5.3 Europe Pharma Contract Sales Market Size Estimation and Forecast by Co-promotion
• 8.6 Europe Pharma Contract Sales Market Size Estimation and Forecast by Therapeutics
• 8.7 Germany Pharma Contract Sales Market Analysis
• 8.8 France Pharma Contract Sales Market Analysis
• 8.9 UK Pharma Contract Sales Market Analysis
• 8.10 Italy Pharma Contract Sales Market Analysis
• 8.11 Spain Pharma Contract Sales Market Analysis
• 8.12 Russia Pharma Contract Sales Market Analysis
• 8.13 Rest of Europe Pharma Contract Sales Market Analysis

9 Asia Pacific Pharma Contract Sales Market Analysis

• 9.1 Key Findings
• 9.2 Asia Pacific Pharma Contract Sales Market Attractiveness Index
• 9.3 Asia Pacific Pharma Contract Sales Market by Country, 2023, 2028 & 2033 (US$ Million)
• 9.4 Asia Pacific Pharma Contract Sales Market Size Estimation and Forecast by Country
• 9.5 Asia Pacific Pharma Contract Sales Market Size Estimation and Forecast by Type
  • 9.5.1 Asia Pacific Pharma Contract Sales Market Size Estimation and Forecast by Personal Promotion
  • 9.5.2 Asia Pacific Pharma Contract Sales Market Size Estimation and Forecast by Non-personal Promotion
  • 9.5.3 Asia Pacific Pharma Contract Sales Market Size Estimation and Forecast by Co-promotion
• 9.6 Asia Pacific Pharma Contract Sales Market Size Estimation and Forecast by Therapeutics
• 9.7 Japan Pharma Contract Sales Market Analysis
• 9.8 China Pharma Contract Sales Market Analysis
• 9.9 India Pharma Contract Sales Market Analysis
• 9.10 Australia Pharma Contract Sales Market Analysis
• 9.11 South Korea Pharma Contract Sales Market Analysis
• 9.12 Rest of Asia Pacific Pharma Contract Sales Market Analysis

10 Latin America Pharma Contract Sales Market Analysis

• 10.1 Key Findings
• 10.2 Latin America Pharma Contract Sales Market Attractiveness Index
• 10.3 Latin America Pharma Contract Sales Market by Country, 2023, 2028 & 2033 (US$ Million)
• 10.4 Latin America Pharma Contract Sales Market Size Estimation and Forecast by Country
• 10.5 Latin America Pharma Contract Sales Market Size Estimation and Forecast by Type
  • 10.5.1 Latin America Pharma Contract Sales Market Size Estimation and Forecast by Personal Promotion
  • 10.5.2 Latin America Pharma Contract Sales Market Size Estimation and Forecast by Non-personal Promotion
  • 10.5.3 Latin America Pharma Contract Sales Market Size Estimation and Forecast by Co-promotion
• 10.6 Latin America Pharma Contract Sales Market Size Estimation and Forecast by Therapeutics
• 10.7 Brazil Pharma Contract Sales Market Analysis
• 10.8 Mexico Pharma Contract Sales Market Analysis
• 10.9 Rest of Latin America Pharma Contract Sales Market Analysis

11 MEA Pharma Contract Sales Market Analysis

• 11.1 Key Findings
• 11.2 MEA Pharma Contract Sales Market Attractiveness Index
• 11.3 MEA Pharma Contract Sales Market by Country, 2023, 2028 & 2033 (US$ Million)
• 11.4 MEA Pharma Contract Sales Market Size Estimation and Forecast by Country
• 11.5 MEA Pharma Contract Sales Market Size Estimation and Forecast by Type
  • 11.5.1 MEA Pharma Contract Sales Market Size Estimation and Forecast by Personal Promotion
  • 11.5.2 MEA Pharma Contract Sales Market Size Estimation and Forecast by Non-personal Promotion
  • 11.5.3 MEA Pharma Contract Sales Market Size Estimation and Forecast by Co-promotion
• 11.6 MEA Pharma Contract Sales Market Size Estimation and Forecast by Therapeutics
• 11.7 GCC Pharma Contract Sales Market Analysis
• 11.8 South Africa Pharma Contract Sales Market Analysis
• 11.9 Rest of MEA Pharma Contract Sales Market Analysis

12 Company Profiles

• 12.1 Competitive Landscape, 2022
• 12.2 Strategic Outlook
• 12.3 CMIC HOLDINGS Co., LTD.
  • 12.3.1 Company Snapshot
  • 12.3.2 Company Overview
  • 12.3.3 Financial Analysis
    • 12.3.3.1 Net Revenue, 2017-2022
  • 12.3.4 Solution Benchmarking
  • 12.3.5 Strategic Outlook
• 12.4 IQVIA Inc.
  • 12.4.1 Company Snapshot
  • 12.4.2 Company Overview
  • 12.4.3 Financial Analysis
    • 12.4.3.1 Net Revenue, 2017-2022
    • 12.4.3.2 Regional Market Shares, 2022
  • 12.4.4 Solution Benchmarking
  • 12.4.5 Strategic Outlook
• 12.5 Syneos Health
  • 12.5.1 Company Snapshot
  • 12.5.2 Company Overview
  • 12.5.3 Financial Analysis
    • 12.5.3.1 Net Revenue, 2017-2022
    • 12.5.3.2 Regional Market Shares, 2022
  • 12.5.4 Solution Benchmarking
  • 12.5.5 Strategic Outlook
• 12.6 Inizio Group Limited
  • 12.6.1 Company Snapshot
  • 12.6.2 Company Overview
  • 12.6.3 Financial Analysis
    • 12.6.3.1 Net Revenue, 2017-2022
    • 12.6.3.2 Regional Market Shares, 2022
  • 12.6.4 Solution Benchmarking
  • 12.6.5 Strategic Outlook
• 12.7 Uniphar Group Plc
  • 12.7.1 Company Snapshot
  • 12.7.2 Company Overview
  • 12.7.3 Financial Analysis
    • 12.7.3.1 Net Revenue, 2017-2022
  • 12.7.4 Solution Benchmarking
  • 12.7.5 Strategic Outlook
• 12.8 ICON plc
  • 12.8.1 Company Snapshot
  • 12.8.2 Company Overview
  • 12.8.3 Financial Analysis
    • 12.8.3.1 Net Revenue, 2017-2022
    • 12.8.3.2 Regional Market Shares, 2022
  • 12.8.4 Solution Benchmarking
• 12.9 Amplity Health
  • 12.9.1 Company Snapshot
  • 12.9.2 Company Overview
  • 12.9.3 Solution Benchmarking
  • 12.9.4 Strategic Outlook
• 12.10 Apodi
  • 12.10.1 Company Snapshot
  • 12.10.2 Company Overview
  • 12.10.3 Solution Benchmarking
• 12.11 Marvecs GmbH
  • 12.11.1 Company Snapshot
  • 12.11.2 Company Overview
  • 12.11.3 Solution Benchmarking
  • 12.11.4 Strategic Outlook
• 12.12 ONCALL, LLC.
  • 12.12.1 Company Snapshot
  • 12.12.2 Company Overview
  • 12.12.3 Solution Benchmarking
• 12.13 PUBLICIS GROUPE
  • 12.13.1 Company Snapshot
  • 12.13.2 Company Overview
  • 12.13.3 Financial Analysis
    • 12.13.3.1 Net Revenue, 2017-2022
    • 12.13.3.2 Regional Market Shares, 2022
  • 12.13.4 Solution Benchmarking
  • 12.13.5 Strategic Outlook
• 12.14 SOFIP
  • 12.14.1 Company Snapshot
  • 12.14.2 Company Overview
  • 12.14.3 Solution Benchmarking
• 12.15 Granard Pharmaceutical Sales & Marketing
  • 12.15.1 Company Snapshot
  • 12.15.2 Company Overview
  • 12.15.3 Solution Benchmarking
• 12.16 Vanguard Pharma
  • 12.16.1 Company Snapshot
  • 12.16.2 Company Overview
  • 12.16.3 Solution Benchmarking
• 12.17 GTS Solution
  • 12.17.1 Company Snapshot
  • 12.17.2 Company Overview
  • 12.17.3 Solution Benchmarking
• 12.18 MaBiCo
  • 12.18.1 Company Snapshot
  • 12.18.2 Company Overview
  • 12.18.3 Solution Benchmarking
• 12.19 Sales Partnerships, Inc.
  • 12.19.1 Company Snapshot
  • 12.19.2 Company Overview
  • 12.19.3 Solution Benchmarking
• 12.20 QFR Solution
  • 12.20.1 Company Snapshot
  • 12.20.2 Company Overview
  • 12.20.3 Solution Benchmarking

13 Conclusion and Recommendations

• 13.1 Concluding Remarks from Visiongain
• 13.2 Recommendations for Market Players